Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 137.91 |
| Open | 135.87 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 900 |
| Day's Range | 133.82 - 141.41 |
| 52 Week Range | 119.01 - 497.49 |
| Volume | |
| Avg. Volume | 7,197,150 |
| Market Cap | 54.199B |
| Beta (5Y Monthly) | 1.54 |
| PE Ratio (TTM) | 4.82 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Departure of Jorge Gomez and Continuation of David Meline as Chief Financial Officer
CAMBRIDGE, MA / ACCESSWIRE / May 11, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the Company, effective immediately.
- ACCESSWIRE
Moderna to Host Annual Science and Technology Day on May 17, 2022
CAMBRIDGE, MA / ACCESSWIRE / May 9, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that that it will host its in-person Science and Technology Day for analysts and investors at 9:00 a.
- ACCESSWIRE
Moderna Reports First Quarter 2022 Financial Results and Provides Business Updates
First quarter 2022 revenues of $6.1 billion; GAAP net-income of $3.
© 2022 Yahoo. All rights reserved.
